New: Our latest case study on qFibrosis' role in the successful development of Rezdiffra

Dean Tai

Co-founder & Chief Scientific Officer (CSO)

As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies. He has established multi-centre clinical trials with key opinion leaders, and successfully coordinated clinical validation worldwide using HistoIndex’s proprietary imaging and analysis technology .